SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-034835
Filing Date
2020-07-30
Accepted
2020-07-30 19:58:55
Documents
69
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q torc-10q_20200630.htm   iXBRL 10-Q 1720096
2 EX-31.1 torc-ex311_6.htm EX-31.1 15641
3 EX-31.2 torc-ex312_8.htm EX-31.2 15742
4 EX-32.1 torc-ex321_7.htm EX-32.1 7788
  Complete submission text file 0001564590-20-034835.txt   6626665

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA torc-20200630.xsd EX-101.SCH 45252
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE torc-20200630_cal.xml EX-101.CAL 33028
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE torc-20200630_def.xml EX-101.DEF 155630
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE torc-20200630_lab.xml EX-101.LAB 349994
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE torc-20200630_pre.xml EX-101.PRE 281573
10 EXTRACTED XBRL INSTANCE DOCUMENT torc-10q_20200630_htm.xml XML 1347788
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 201062568
SIC: 2834 Pharmaceutical Preparations